Success Story: Advancing Targeted Nanomedicine and Cancer Therapeutics: NIW Approval Secured for a Pharmaceutical Sciences Researcher

Posted by wegreened on October 22, 2026 in NIW, Pharmaceutical Sciences

Client’s Testimonial:

“Thank you very much for your kind message. I am very grateful for your assistance with my EB-2 NIW petition and for your support throughout the process.”

On September 17^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. Student in the Field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Ph.D. Student

Country of Origin: Iran

State of Residence at the Time of Filing: Texas

Approval Notice Date: September 17^th, 2026

Processing Time: 12 months, 6 days (Premium Processing Upgrade Requested)

Case Summary:

The client holds a Doctor of Pharmacy (Pharm.D.) degree and works in the field of pharmaceutical sciences. Her proposed endeavor focuses on designing and developing liposomal nanoparticles that enhance anticancer drug efficacy to produce more effective and targeted treatments. This research directly addresses major public health challenges supporting national priorities such as the federal Cancer Moonshot initiative. The national value of her work is further demonstrated by major research funding supported by the National Institutes of Health (NIH).

To establish that the client was well positioned to advance her endeavor, the petition highlighted her scholarly output of 8 peer-reviewed journal articles (1 first-authored) and 1 first-authored conference abstract, which have accumulated 62 citations from researchers worldwide. Rather than presenting these metrics as self-evidently sufficient, our legal team contextualized her citation performance for the adjudicator, demonstrating that three of her papers ranked among the top 0.1%, top 10%, and top 20% most-cited articles in pharmacology and toxicology for their respective publication years. Independent scientists actively rely on her methodologies to advance targeted drug delivery systems, evaluate nanocarrier stability, and investigate tumor microenvironment interactions.

Professional recognition was further demonstrated through her service completing at least 9 peer reviews for authoritative scientific journals. The petition was strongly supported by 4 recommendation letters from field experts who confirmed the technical necessity and national importance of her nanomedicine research. As one expert noted:

"[Client’s] ongoing research is vital to ensuring that the U.S. remains an influential power in biomedical innovation."

USCIS approved the client’s I-140 NIW petition, recognizing the clear national importance of her work in pharmaceutical sciences, targeted liposomal delivery, and oncology drug development in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 69,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 69,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%